Cofoe Medical Technology Co., Ltd. Class A

As of June 30, 2026, Cofoe Medical Technology Co., Ltd. Class A carries a market capitalization of 11.24B, placing it among publicly traded companies globally. Its enterprise value stands at 9.08B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Cofoe Medical Technology Co., Ltd. Class A's next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, Cofoe Medical Technology Co., Ltd. Class A has 235.90M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Cofoe Medical Technology Co., Ltd. Class A maintains a current ratio of 2.63, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Cofoe Medical Technology Co., Ltd. Class A recorded 51.73M in income tax expense.

As of the close on October 23, 2026, Cofoe Medical Technology Co., Ltd. Class A's stock has gained approximately 29.75% over the past 52 weeks. The 50-day moving average sits at 51.84, while the 200-day moving average is 52.18.

As of June 30, 2026, Cofoe Medical Technology Co., Ltd. Class A holds 3.06B in cash and equivalents against 867.65M in total debt, resulting in a net debt position of -1.72B. Total book value stands at 5.53B, with working capital of 2.87B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Cofoe Medical Technology Co., Ltd. Class A paid dividends of 1.22 per share.

Cofoe Medical Technology Co., Ltd. Class A's most recent stock split took place on May 20, 2022 with a 10:13 split ratio.